• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[重症发热伴血小板减少综合征凝血功能障碍的临床特征及意义]

[Clinical features and significance of coagulation dysfunction in severe fever with thrombocytopenia syndrome].

作者信息

Xu L, Wang H, Liang B Y, Wang T, Zheng X, Peng C

机构信息

Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 432200, China.

出版信息

Zhonghua Nei Ke Za Zhi. 2022 Jul 1;61(7):793-796. doi: 10.3760/cma.j.cn112138-20211013-00702.

DOI:10.3760/cma.j.cn112138-20211013-00702
PMID:35764563
Abstract

To analyze the changes of coagulation function in severe fever with thrombocytopenia syndrome (SFTS) and its relationship with thrombocytopenia, and to explore its value as an early predictor of the severity of SFTS. The clinical data of 428 SFTS patients (70 deaths and 358 survivors) admitted to the Department of Infectious Disease at Wuhan Union Hospital from January 2014 to July 2020 were retrospectively analyzed. The differences of coagulation parameters and disseminated intravascular coagulation (DIC) scores between the two groups were compared. The results showed that abnormal coagulation function was commonly presented in SFTS patients. Bleeding was more frequent in mortality group (41.4% vs. 26.5%). The D-dimer levels in mortality patients were significantly higher above normal range. Activated partial thrombin time (APTT) and thrombin time (TT) were significantly prolonged. The levels of prothrombin time (PT), TT, APTT, international standardized ratio (INR) and D-dimer between mortality group and survival group started to separate from day 5-6. The difference of fibrinogen (FIB) level developed on day 7-8, while platelet counts between the two groups were significant different from day 9-10. The mortality rate increased according to the increase of baseline DIC score. When DIC score reached 6, the mortality rate surged to 66.67%. Excessive platelet consumption is mediated by significant coagulation abnormalities during disease course, and coagulation parameters are more sensitive than platelet count as an early predictor of severe SFTS.

摘要

分析发热伴血小板减少综合征(SFTS)患者凝血功能变化及其与血小板减少的关系,探讨其作为SFTS严重程度早期预测指标的价值。回顾性分析2014年1月至2020年7月在武汉协和医院感染科收治的428例SFTS患者(70例死亡,358例存活)的临床资料。比较两组凝血参数及弥散性血管内凝血(DIC)评分的差异。结果显示,SFTS患者普遍存在凝血功能异常。死亡组出血更常见(41.4%对26.5%)。死亡患者D-二聚体水平显著高于正常范围。活化部分凝血活酶时间(APTT)和凝血酶时间(TT)显著延长。死亡组与存活组的凝血酶原时间(PT)、TT、APTT、国际标准化比值(INR)和D-二聚体水平在第5 - 6天开始出现分离。纤维蛋白原(FIB)水平差异在第7 - 8天出现,而两组血小板计数在第9 - 10天有显著差异。死亡率随基线DIC评分增加而升高。当DIC评分达到6分时,死亡率飙升至66.67%。疾病过程中显著的凝血异常介导了血小板过度消耗,凝血参数作为SFTS严重程度的早期预测指标比血小板计数更敏感。

相似文献

1
[Clinical features and significance of coagulation dysfunction in severe fever with thrombocytopenia syndrome].[重症发热伴血小板减少综合征凝血功能障碍的临床特征及意义]
Zhonghua Nei Ke Za Zhi. 2022 Jul 1;61(7):793-796. doi: 10.3760/cma.j.cn112138-20211013-00702.
2
[Study on the value of prothrombin time for predicting the severity and prognosis of septic patients].[凝血酶原时间对脓毒症患者病情严重程度及预后预测价值的研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Jul;34(7):682-688. doi: 10.3760/cma.j.cn121430-20210614-00876.
3
The AST/ALT Ratio (De Ritis Ratio) Represents an Unfavorable Prognosis in Patients in Early-Stage SFTS: An Observational Cohort Study.AST/ALT 比值(De Ritis 比值)反映了早期发热伴血小板减少综合征患者的不良预后:一项观察性队列研究。
Front Cell Infect Microbiol. 2022 Feb 8;12:725642. doi: 10.3389/fcimb.2022.725642. eCollection 2022.
4
[Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].[硫化氢对兔组织因子诱导的弥散性血管内凝血的影响]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Feb;27(2):92-6. doi: 10.3760/cma.j.issn.2095-4352.2015.02.003.
5
[Coagulation tests in septic surgical patients].[脓毒症外科患者的凝血试验]
Acta Med Croatica. 2004;58(5):389-94.
6
Levels of peripheral blood routine, biochemical and coagulation parameters in patients with hemorrhagic fever with renal syndrome and their relationship with prognosis: an observational cohort study.出血热伴肾综合征患者外周血常规、生化和凝血参数水平及其与预后的关系:一项观察性队列研究。
BMC Infect Dis. 2024 Jan 11;24(1):75. doi: 10.1186/s12879-023-08777-w.
7
SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)诱导的血小板减少作为一种重要的生物标志物,与新型冠状病毒肺炎(COVID-19)患者的凝血功能异常、血管内血栓形成风险增加及死亡率显著相关。
Exp Hematol Oncol. 2020 Jul 17;9:16. doi: 10.1186/s40164-020-00172-4. eCollection 2020.
8
[Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].[初诊急性早幼粒细胞白血病合并弥散性血管内凝血的经验性治疗分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Apr;22(2):315-22. doi: 10.7534/j.issn.1009-2137.2014.02.010.
9
[Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].[转移性前列腺癌合并慢性弥散性血管内凝血致急性肾衰竭,酷似血栓性血小板减少性紫癜和溶血尿毒综合征:病例相关的发病机制、鉴别诊断及治疗]
Magy Onkol. 2010 Dec;54(4):351-7. doi: 10.1556/MOnkol.54.2010.4.9.
10
The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study.重组人可溶性血栓调节蛋白治疗产科弥散性血管内凝血的疗效:一项回顾性研究。
Crit Care. 2015 Oct 20;19:369. doi: 10.1186/s13054-015-1086-3.

引用本文的文献

1
Unveiling fatal risk factors: Predicting hemophagocytic lymphohistiocytosis in SFTS patients.揭示致命风险因素:预测发热伴血小板减少综合征患者的噬血细胞性淋巴组织细胞增生症
PLoS Negl Trop Dis. 2025 Jun 24;19(6):e0013207. doi: 10.1371/journal.pntd.0013207. eCollection 2025 Jun.
2
Clinical characteristics and outcomes of disseminated intravascular coagulation in patients with severe fever with thrombocytopenia syndrome.严重发热伴血小板减少综合征患者弥散性血管内凝血的临床特征及预后
BMC Infect Dis. 2025 Apr 11;25(1):508. doi: 10.1186/s12879-025-10900-y.
3
Elevated thrombosis-related biomarkers as predictors of disease severity and mortality in patients with severe fever with thrombocytopenia syndrome.
升高的血栓形成相关生物标志物作为严重发热伴血小板减少综合征患者疾病严重程度和死亡率的预测指标
BMC Infect Dis. 2025 Feb 18;25(1):235. doi: 10.1186/s12879-025-10574-6.
4
Establishment and validation of a prognostic nomogram for severe fever with thrombocytopenia syndrome: A retrospective observational study.发热伴血小板减少综合征预后列线图的建立与验证:一项回顾性观察研究。
PLoS One. 2024 Oct 24;19(10):e0311924. doi: 10.1371/journal.pone.0311924. eCollection 2024.
5
Construction and validation of a dynamic nomogram using Lasso-logistic regression for predicting the severity of severe fever with thrombocytopenia syndrome patients at admission.构建并验证了一个基于 Lasso-Logistic 回归的动态列线图,用于预测入院时严重发热伴血小板减少综合征患者的严重程度。
BMC Infect Dis. 2024 Sep 18;24(1):996. doi: 10.1186/s12879-024-09867-z.
6
Establishment and validation of a clinical risk scoring model to predict fatal risk in SFTS hospitalized patients.建立并验证一个临床风险评分模型,以预测发热伴血小板减少综合征住院患者的死亡风险。
BMC Infect Dis. 2024 Sep 13;24(1):975. doi: 10.1186/s12879-024-09898-6.